A Phase II Study to Determine the Safety and Efficacy of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase (IDO) Enzyme INCB024360 in Patients with Myelodysplastic Syndromes
Titel:
A Phase II Study to Determine the Safety and Efficacy of the Oral Inhibitor of Indoleamine 2,3-Dioxygenase (IDO) Enzyme INCB024360 in Patients with Myelodysplastic Syndromes
Auteur:
Komrokji, Rami S. Wei, Sheng Mailloux, Adam W. Zhang, Ling Padron, Eric Sallman, David Lancet, Jeffrey E. Tinsley, Sara Nardelli, Lisa A. Pinilla-Ibarz, Javier Epling-Burnette, Pearlie K. List, Alan F.